Recent
‍Blog Posts

Defining a new therapeutic category requires more than clinical progress, it requires new ways of thinking. Explore our insights on Hybrid Drugs and the future of integrated, adaptive care.

The Brain-Immune Link: Establishing the Biological Foundation of Hybrid Drugs
Feb 15, 2026

The Brain-Immune Link: Establishing the Biological Foundation of Hybrid Drugs

As the pioneer of the Hybrid Drug therapeutic category - the integration of pharmaceutical agents with regulated, prescription-based digital protocols - Remepy continues to demonstrate how structured digital interventions can modulate systemic physiology to improve clinical outcomes.

Digital Therapeutics for Parkinson’s Disease: The Hybrid Drug Approach
Dec 18, 2025

Digital Therapeutics for Parkinson’s Disease: The Hybrid Drug Approach

Digital therapeutics are rapidly becoming part of how Parkinson’s disease is monitored and managed. Apps can now guide exercise, support speech and cognition, track symptoms, and help people stick to complex treatment routines.

Unlocking the Aging Brain's Potential while navigating in the dark
Nov 2, 2025

Unlocking the Aging Brain's Potential while navigating in the dark

A New Research Shows Cognition Improvement by Using an Innovative Mobile App

What is PDURS: Exploring FDA’s Prescription Drug Use-Related Software Draft Guidance
Oct 29, 2025

What is PDURS: Exploring FDA’s Prescription Drug Use-Related Software Draft Guidance

FDA’s PDURS Draft Guidance will drive better integration between software and drugs

Can a Mobile App Work Like an Antibody
Oct 27, 2025

Can a Mobile App Work Like an Antibody

Modulating Cytokines with Code: A New Frontier in Digital Medicine

Managing Disease at the Intersection of Biology, Behavior & Therapy